Early-onset schizophrenia: studying the links between cognitive and clinical dimensions

Cogn Neuropsychiatry. 2023 Sep;28(5):377-390. doi: 10.1080/13546805.2023.2266871. Epub 2023 Nov 5.

Abstract

Background: Early-onset schizophrenia (EOS), a rare and severe chronic psychiatric condition, is defined by an onset of schizophrenia symptoms before the age of 18. Core symptoms also include cognitive impairments. However, little is known about links between psychiatric symptoms of EOS and cognitive abilities.

Objective: To explore the clinical and neurocognitive profiles of EOS patients and their links.

Method: EOS patients have been phenotyped using standardised psychiatric assessments for DSM-5 diagnoses (K-SADS-PL) and for symptoms (PANSS and SANS), together with neurocognitive evaluations.

Results: The EOS sample (n = 27, 12.4 +/-3.2 years) presented hallucinations (83%), negative symptoms (70%) and delusion (59%). 81% of patients presented comorbidities such as anxiety disorders (33%), autism spectrum disorder (26%) and attention-deficit hyperactivity disorder (26%). Patients presented borderline intellectual deficiency (total IQ = 72.5 +/-4.7), with low performances in working memory subtest. We highlight a positive correlation between the IQ and intensity of positive symptoms (PANSS) and between the IQ and a first treatment being administered at an older age. We also highlight a negative correlation between the IQ and attention items of SANS.

Conclusion: Cognitive skills are correlated with symptom intensity in EOS patients. An older age of onset seems to be a protective factor for cognitive development.

Keywords: Early-Onset Schizophrenia; clinical symptoms; cognitive remediation; comorbidities; neurocognitive deficit.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autism Spectrum Disorder* / diagnosis
  • Cognition
  • Cognitive Dysfunction*
  • Comorbidity
  • Humans
  • Schizophrenia* / diagnosis
  • Schizophrenia* / drug therapy